Avecho Biotechnology Limited
AVEFF
$0.0045
-$0.0129-74.14%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 301.84% | 204.56% | 134.13% | 13.11% | -59.44% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 301.84% | 204.56% | 134.13% | 13.11% | -59.44% |
| Cost of Revenue | 5.10% | -3.05% | -10.79% | 21.85% | 82.24% |
| Gross Profit | 657.50% | 905.32% | 2,172.43% | 0.06% | -126.79% |
| SG&A Expenses | 36.31% | 5.85% | -17.24% | -27.00% | -36.18% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 25.59% | 15.89% | 6.36% | -5.83% | -17.47% |
| Operating Income | 1.48% | 6.48% | 11.51% | 9.28% | 8.15% |
| Income Before Tax | -1.53% | 4.36% | 10.26% | 8.61% | 8.04% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.53% | 4.36% | 10.26% | 8.61% | 8.04% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.53% | 4.36% | 10.26% | 8.61% | 8.04% |
| EBIT | 1.48% | 6.48% | 11.51% | 9.28% | 8.15% |
| EBITDA | 1.19% | 6.09% | 11.05% | 8.37% | 6.80% |
| EPS Basic | 0.00% | 30.00% | 50.00% | 46.15% | 42.86% |
| Normalized Basic EPS | -50.00% | 0.00% | 33.33% | 42.86% | 50.00% |
| EPS Diluted | 0.00% | 30.00% | 50.00% | 46.15% | 42.86% |
| Normalized Diluted EPS | -50.00% | 0.00% | 33.33% | 42.86% | 50.00% |
| Average Basic Shares Outstanding | 9.80% | 22.97% | 39.73% | 45.85% | 53.21% |
| Average Diluted Shares Outstanding | 9.80% | 22.97% | 39.73% | 45.85% | 53.21% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |